RHABDOID TUMOUR

This adverse event was reported 52 times

RHABDOID TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXRAZOXANE FOR INJECTION 5 0.0053
1 GRANULOCYTE COLONY STIMULATING FACTOR 2 0.0009
2 DACTINOMYCIN 2 0.0009
3 IFOSFAMIDE FOR INJECTION 16 0.0007
4 MESNA INJECTION 6 0.0007
5 MESNA 6 0.0007
6 ETOPOSIDE 31 0.0004
7 TOPOTECAN HYDROCHLORIDE 1 0.0004
8 DEFIBROTIDE SODIUM 1 0.0003
9 BRIGATINIB 1 0.0003
See all drugs enriched for association with RHABDOID TUMOUR